{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Mitochondrial+Disease&page=9", "query": { "condition": "Inherited Mitochondrial Disease", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 206, "total_pages": 21, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Mitochondrial+Disease&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Inherited+Mitochondrial+Disease&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T11:48:25.552Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00002273", "title": "A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colitis", "HIV Infections" ], "interventions": [ { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "MALE", "summary": "21 Years and older · Male only" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002273" }, { "nct_id": "NCT00000894", "title": "Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cytomegalovirus Retinitis", "HIV Infections" ], "interventions": [ { "name": "Cidofovir", "type": "DRUG" }, { "name": "Probenecid", "type": "DRUG" }, { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 300, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2011-02-23", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 12, "location_summary": "Los Angeles, California • Miami, Florida • Atlanta, Georgia + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000894" }, { "nct_id": "NCT00697073", "title": "Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Friedreich's Ataxia" ], "interventions": [ { "name": "Idebenone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Santhera Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "8 Years to 18 Years" }, "enrollment_count": 68, "start_date": "2008-07", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2023-07-11", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 2, "location_summary": "Los Angeles, California • Philadelphia, Pennsylvania", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00697073" }, { "nct_id": "NCT04349514", "title": "A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia (TRACK-FA)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Friedreich Ataxia" ], "interventions": [ { "name": "Natural history", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Monash University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 300, "start_date": "2021-02-10", "completion_date": "2025-10", "has_results": false, "last_update_posted_date": "2024-11-27", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 3, "location_summary": "Gainesville, Florida • Minneapolis, Minnesota • Philadelphia, Pennsylvania", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04349514" }, { "nct_id": "NCT02255435", "title": "A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Friedreich Ataxia" ], "interventions": [ { "name": "Omaveloxolone Capsules, 2.5 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 5 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 20 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 40 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 80 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 160 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 300 mg", "type": "DRUG" }, { "name": "Omaveloxolone Capsules, 150 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "16 Years to 40 Years" }, "enrollment_count": 172, "start_date": "2015-01-31", "completion_date": "2025-12-19", "has_results": true, "last_update_posted_date": "2026-09-03", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 7, "location_summary": "Los Angeles, California • Gainesville, Florida • Tampa, Florida + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT02255435" }, { "nct_id": "NCT06891443", "title": "Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Leber Congenital Amaurosis 10", "Blindness", "Leber Congenital Amaurosis", "Sensation Disorders", "Vision Disorder", "Neurological Manifestations", "Eye Diseases, Hereditary", "Eye Diseases", "Eye Disorders Congenital", "Retinal Disease" ], "interventions": [ { "name": "sepofarsen", "type": "DRUG" }, { "name": "Placebo IVT", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Laboratoires Thea", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 32, "start_date": "2025-06-04", "completion_date": "2028-10", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 5, "location_summary": "San Francisco, California • Miami, Florida • Iowa City, Iowa + 2 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06891443" }, { "nct_id": "NCT00000768", "title": "A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colitis", "HIV Infections" ], "interventions": [ { "name": "Glutamic acid hydrochloride", "type": "DRUG" }, { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 24, "start_date": null, "completion_date": "1998-08", "has_results": false, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 5, "location_summary": "Birmingham, Alabama • San Francisco, California • St Louis, Missouri + 2 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Francisco", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000768" }, { "nct_id": "NCT06623890", "title": "A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Friedreich Ataxia" ], "interventions": [ { "name": "Omaveloxolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 300, "start_date": "2024-12-12", "completion_date": "2029-10-01", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 4, "location_summary": "Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06623890" }, { "nct_id": "NCT00002330", "title": "A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cytomegalovirus Retinitis", "HIV Infections" ], "interventions": [ { "name": "Ganciclovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roche Global Development", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 280, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002330" }, { "nct_id": "NCT03418740", "title": "Neurology Measures in FA Children", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Friedreich Ataxia" ], "interventions": [], "intervention_types": [], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "2 Years to 18 Years" }, "enrollment_count": 108, "start_date": "2017-11-20", "completion_date": "2023-02-02", "has_results": true, "last_update_posted_date": "2025-01-16", "last_synced_at": "2026-10-14T11:48:25.552Z", "location_count": 3, "location_summary": "Los Angeles, California • Gainesville, Florida • Philadelphia, Pennsylvania", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03418740" } ] }